Could Spring Trigger a Fourth COVID-19 Wave in the US?
As the US nears 30 million COVID-19 cases and spring arrives, health experts warn of a potential fourth wave driven by variants and relaxed restrictions.
VaccineUpdate
Read More
South Africa Switches to J&J COVID Vaccines After AstraZeneca Halt
South Africa shifts to Johnson & Johnson COVID-19 vaccines after AstraZeneca shows limited efficacy against local variant, prioritizing public health strategy.
US Advances COVID-19 Response with New Rapid Test and Vaccine Approval
The U.S. FDA approves a new at-home rapid COVID-19 test and is set to approve Moderna’s second vaccine, aiming to immunize 20 million Americans by December.